Astrazeneca Pharma India standalone net profit declines 22.95% in the March 2026 quarter
2026-05-27 10:12:58Astrazeneca Pharma India standalone net profit declines 22.95% in the March 2026 quarter Business Standard...
Read MoreDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel
16-Jun-2026 | Source : BSEPlease find the enclosed letter of the Company as per the captioned subject for reference.
Closure of Trading Window
15-Jun-2026 | Source : BSEPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management Personnels
12-Jun-2026 | Source : BSEPlease find the enclosed intimation of the Company with respect to the captioned subject for your reference.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1600% dividend, ex-date: 18 Jul 25
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available